Peter Campochiaro, MD

Peter Campochiaro, MD, is a clinician-scientist and the George S. and Dolores Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He received his MD from Johns Hopkins University School of Medicine. He completed his residency in ophthalmology at the University of Virginia School of Medicine, a vitreoretinal fellowship with Dr Ronald Michels at the Wilmer Eye Institute, and cell biology and neurochemisty research training at Johns Hopkins. 

Dr Campochiaro studies ocular neovascularization and excessive vascular leakage, which occurs in age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. He utilized mouse models to help define the molecular pathogenesis of ocular neovascularization and excessive vascular leakage, including the roles of VEGF, HIF-1, and Tie2. His clinical trial group showed the benefits of inhibiting VEGF in diabetic macular edema and retinal vein occlusions. He has helped to develop strategies to provide sustained suppression of VEGF. His laboratory also demonstrated that oxidative damage contributes to cone cell death in retinitis pigmentosa, and this has also advanced to testing in clinical trials.